MapLight Therapeutics Ownership | Who Owns MapLight Therapeutics?


OverviewFinancialsChart

MapLight Therapeutics Ownership Summary


MapLight Therapeutics is owned by 5.89% institutional investors, 51.44% insiders, and 42.67% retail investors. Novo is the largest institutional shareholder, holding 8.37% of MPLT shares.

MPLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMapLight Therapeutics5.89%51.44%42.67%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Novo3.69M8.37%$74.95M
Fcpm iii services b.v.3.23M7.33%$65.59M
T. rowe price investment management2.80M6.36%$56.96M
Goldman sachs group1.99M4.53%$40.56M
Blackrock funding, inc. /de1.34M3.04%$27.24M
Blue owl capital lp1.01M2.29%$20.45M
Nan fung group971.25K2.21%$19.75M
5am venture management950.01K2.16%$19.31M
Vanguard group869.67K2.10%$15.28M
Sanofi912.04K2.07%$18.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group971.25K16.28%$19.75M
Fcpm iii services b.v.3.23M9.08%$65.59M
Velan capital investment management lp492.89K6.28%$10.02M
Novo3.69M6.07%$74.95M
Sanofi912.04K5.52%$18.54M
Blue owl capital lp1.01M5.49%$20.45M
5am venture management950.01K5.36%$19.31M
Pivotal bioventure partners investment advisor611.45K4.44%$12.43M
Superstring capital management lp192.14K2.79%$3.91M
Dafna capital management171.01K0.79%$3.48M

Top Buyers

HolderShares% AssetsChange
Vanguard group869.67K0.00%869.67K
Blue owl capital lp1.01M5.49%678.87K
Ra capital management248.29K0.05%248.29K
Blackrock funding, inc. /de1.34M0.00%244.22K
Ubs group236.51K0.00%218.22K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---550.00K
Jain global---327.69K
Citadel advisors---190.14K
Ameriprise financial---66.87K
Lazard asset management142.02K0.00%-65.48K

New Positions

HolderShares% AssetsChangeValue
Vanguard group869.67K0.00%869.67K$15.28M
Ra capital management248.29K0.05%248.29K$5.05M
Superstring capital management lp192.14K2.79%192.14K$3.91M
Vanguard fiduciary trust131.23K0.00%131.23K$2.67M
Price t rowe associates inc /md/112.71K0.00%112.71K$2.29M

Sold Out

HolderChange
Federation des caisses desjardins du quebec-500.00
Amalgamated bank-530.00
Royal bank of canada-582.00
Lynx1 capital management lp-13.48K
Millennium management-13.95K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202628-62.16%2,594,337-88.75%50.19%16-78.38%5-
Dec 31, 202533-8,880,682-21-33---

MPLT Ownership FAQ


Who Owns MapLight Therapeutics?

MapLight Therapeutics shareholders are primarily institutional investors at 5.89%, followed by 51.44% insiders and 42.67% retail investors. The average institutional ownership in MapLight Therapeutics's industry, Biotech Stocks , is 34.84%, which MapLight Therapeutics falls below.

Who owns the most shares of MapLight Therapeutics?

MapLight Therapeutics’s largest shareholders are Novo (3.69M shares, 8.37%), Fcpm iii services b.v. (3.23M shares, 7.33%), and T. rowe price investment management (2.8M shares, 6.36%). Together, they hold 22.07% of MapLight Therapeutics’s total shares outstanding.

Does Blackrock own MapLight Therapeutics?

BlackRock is not among the top 10 institutional shareholders of MapLight Therapeutics.

Who is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.28% of its assets in 971.25K MapLight Therapeutics shares, valued at 19.75M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools